InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,221.42
(
-0.02%
)
US TECH 100
17,717.16
(
0.20%
)
Dow Jones
39,431.51
(
-0.21%
)
Brent Oil
83.25
(
1.04%
)
Bitcoin
63,120.83
(
2.72%
)
Post# of 3329
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Vector93

Send PM Follow Ignore
Followers 14
Posts 853
Boards Moderated 0
Alias Born 07/18/2014

Vector93

Re: shadolane post# 3111

Wednesday, 11/08/2017 10:49:26 AM

Wednesday, November 08, 2017 10:49:26 AM

Post# of 3329
Analysts estimates are all based on pre-FDA approval, and they are correct, the market for their drug is limited. Now with the expanded label they have access to 650,000 patients who, today, are treated by IV injections, which are time consuming and expensive.

KERX is a pill that you take at home, and it works better. Doctors are going to switch in droves.

Analysts are going to have to revise their estimates of this company, and you’ll see the fair market value will explode.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up